🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This study was designed to investigate the 1 year efficacy and safety of th...
Status
Completed
Location
Novartis Investigative Site
Start Date
2009-06
Trial ID
NCT00929110
Treatments Being Tested
The purpose of this study is to evaluate the safety and the efficacy of Gly...
Status
Completed
Location
Medicines Evaluation Unit
Start Date
2010-08
Trial ID
NCT01176903
Treatments Being Tested
We will detect dynamic hyperinflation (DH) in 40 COPD (chronic obstructive ...
Status
Completed
Location
Arthur F Gelb MD
Start Date
2006-10
Trial ID
NCT00569270
Treatments Being Tested
The primary objective of this trial was to establish non-inferiority of lun...
Status
Completed
Location
Multiple Locations
Start Date
2005-07-28
Trial ID
NCT02242266
The overall objective of this study is to determine an optimal dose and dos...
Status
Completed
Location
Pearl Investigative Site
Start Date
2012-03
Trial ID
NCT01566773
Treatments Being Tested
To compare the bronchodilator efficacy and safety of tiotropium inhalation ...
Status
Completed
Location
Multiple Locations
Start Date
2001-05
Trial ID
NCT02172469
Chronic obstructive pulmonary disease (COPD) is one of the commonest respir...
Status
Completed
Location
Beijing Chao-Yang Hospital
Start Date
2011-11
Trial ID
NCT01455129
Treatments Being Tested
GSK233705 is a high-affinity specific muscarinic receptor (mAChR) antagonis...
Status
Completed
Location
GSK Investigational Site
Start Date
2005-12-12
Trial ID
NCT00279019
Treatments Being Tested
The primary objectives of this study are to assess bronchodilator efficacy ...
Status
Terminated
Location
1184.14.01013 Boehringer Ingelheim Investigational Site
Start Date
2008-04-15
Trial ID
NCT00662740
The purpose of this study is to further figure out differences of glycopyrr...
Status
Completed
Location
Novartis Investigative Site
Start Date
2013-08
Trial ID
NCT01922271
Treatments Being Tested